(Press-News.org) BOSTON, United States — 29 March, 2024 — Based on the success of its 2023 HF-GRO program effort, Hevolution Foundation is issuing a call for applications for the 2024 iteration of the program. HF-GRO is an international effort to accelerate progress in healthy aging research. The major goal is to identify and support research that will further the Hevolution’s mission of extending healthy lifespan for the benefit of all humanity.
HF-GRO will provide up to $25 million in 2024 (the total budget planned over 5 years is $115M) to fund approximately 40-60 projects in aging biology or geroscience. Preference, both in length and funding level, will be given to projects that advance basic biology knowledge towards translation (geroscience).
HF-GRO provides support for research projects in the basic biology of aging, as well as projects that translate advances in basic research from the laboratory towards the clinic (translational geroscience). Work should focus on strategies to improve healthy aging by addressing basic principles of aging biology and geroscience. Projects that deal strictly with clinical problems such as the diagnosis or treatment of disease, or the social context of aging are not eligible. Therefore, this initiative will support research approaches that addresses:
The maintenance and/or improvement of the mechanisms underlying aging
How this might improve health and delay/improve the outcome of age-related diseases and conditions
The Letter of Intent submission deadline for the 2024 program is April 26, 2024. For more information, grant program guidelines, and to submit an application, visit: www.hevolution.com/funding-opportunities
About Hevolution Foundation
Founded on the belief that every person has the right to live a longer, healthier life, Hevolution Foundation is a global catalyst, partner, and convener on a mission to drive efforts to extend healthy human lifespan and understand the processes of aging. With a focus on aging as a treatable process, Hevolution Foundation aims to increase the number of aging-related treatments on the market, compress the timeline of drug development, and increase accessibility to therapeutics that extend healthy lifespan, also known as healthspan. A global non-profit organization headquartered in Riyadh with a North American hub in Boston and an annual budget of up to $1 billion, Hevolution Foundation plans to open offices in other global locations to support a cutting-edge, global ecosystem of talent to propel aging and geroscience research forward and achieve medical breakthroughs to help humanity live healthier, longer. To date, Hevolution has committed $250 million to drive scientific discoveries to make aging healthier for humanity.
Learn more at: https://hevolution.com/ and connect with us on LinkedIn
END
Hevolution Foundation issues $115 million call for applications for geroscience research opportunities
2024-03-29
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Rice study identifies protein responsible for gas vesicle clustering in bacteria
2024-03-29
HOUSTON – (March 29, 2024) – Gas vesicles are hollow structures made of protein found in the cells of certain microorganisms, and researchers at Rice University believe they can be programmed for use in biomedical applications.
“Inside cells, gas vesicles are packed in a beautiful honeycomb pattern. How this pattern is formed has never been thoroughly understood. We are presenting the first identification of a protein that can regulate this patterning, and we believe this will be a milestone in molecular microbiology,” said George Lu, assistant professor of bioengineering and a Cancer Prevention and Research Institute of Texas scholar.
Lu and colleagues have published ...
AADOCR announces recipients of the 2024 Student Competition for Advancing Dental Research Application (SCADA)
2024-03-29
Alexandria, VA – The American Association for Dental, Oral, and Craniofacial Research (AADOCR) has named the recipients of the 2024 Student Competition for Advancing Dental Research Application (SCADA). The recipients were recognized during the Opening Ceremonies of the 53rd Annual Meeting of the AADOCR, which was held in conjunction with the 102nd General Session of the International Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research, on March 13-16, 2024 in New Orleans, LA.
The winners are:
CLINICAL RESEARCH & PUBLIC HEALTH CATEGORY
1st ...
Veterans help provide greater insight into Klinefelter and Jacobs syndromes
2024-03-29
AURORA, Colo. (March 29, 2024) –Researchers at the University of Colorado Anschutz Medical Campus and collaborators across the country have conducted the largest and most diverse study of men with extra X or Y chromosomes in the US using a large dataset of military veterans. The results could lead to better diagnoses of these underrecognized conditions and earlier treatment of associated diseases.
The study was published today in JAMA Network Open.
“One in 400 males have an additional X or Y chromosome, however 86 percent of these individuals are not diagnosed,” said ...
Three renowned Argonne scientists accept joint appointments at the University of Houston
2024-03-29
HOUSTON, March 29, 2024 – Three top researchers with the U.S. Department of Energy’s Argonne National Laboratory have accepted joint appointments in various capacities at the University of Houston. These appointments are part of the memorandum of understanding (MoU) Argonne signed recently with the Greater Houston Partnership. The MoU creates greater collaboration across academia, industry, private investors and government to accelerate and scale decarbonization efforts in the region, with the goal of achieving a net-zero emissions economy by 2050, according to an Argonne press release.
“This strategic collaboration leverages the combined strengths ...
High-resolution images reveal similarities in protein structures between Alzheimer’s disease and Down syndrome
2024-03-29
INDIANAPOLIS – More than 90% of people with Down syndrome, the most common chromosomal disorder in humans and the most frequent genetic cause of intellectual disability, are diagnosed with Alzheimer’s disease by ages 55-60. A new study recently published in Nature Structural and Molecular Biology uses leading-edge cryo-electron microscopy imaging technology to determine whether differences exist between the protein structures in those with Alzheimer’s disease and those with both Alzheimer’s disease and Down syndrome.
“Just like in Alzheimer’s disease, the neuropathological phenotype in those with ...
How blocking a neural receptor responsible for addiction could reduce alcohol use
2024-03-29
LA JOLLA, CA—Scripps Research scientists have found that LY2444296—a compound that selectively blocks the kappa opioid receptor (KOP)—may reduce drinking in cases of alcohol dependence in animal studies. The findings, which were published March 9, 2024, in Scientific Reports, could eventually inform new treatment options for people who experience alcohol use disorder (AUD).
“Compounds designed to selectively block the KOP are very promising because this receptor is involved in a lot of mental illnesses, such as ...
Researchers discover skin biomarkers in infants that predict early development of food allergies
2024-03-29
DENVER — (MARCH 29, 2024) Food allergies occur often in childhood and can be severe or even fatal. Researchers at National Jewish Health are working to develop a program to prevent food allergies and have now identified early predictors of the condition.
During a recent study just published online in the March 2024 issue of the Journal of Allergy & Clinical Immunology, skin tape strips were collected from the forearms of newborns at the age of two months, an age before there ...
Researchers reveal evolutionary path of important proteins
2024-03-29
New research from the University of Wisconsin–Madison decodes the evolutionary pathway of regulatory proteins, the molecules that help control gene expression.
The findings from the Raman Lab in the Department of Biochemistry recently published their findings in the journal Cell Systems. Here’s a rundown on what they discovered:
Proteins acquire and lose functions through evolutionary processes as cells adapt to changes in their environment over time.
Protein evolution is well studied in certain enzymes but is understudied in regulatory proteins, which help control gene expression.
A new, ...
Insilico Medicine presents progress of 5 novel AI cancer drugs at AACR
2024-03-29
Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that five preclinical programs have been accepted as poster presentations in the American Association for Cancer Research Annual Meeting 2024 (AACR 2024) happening April 5-10 in San Diego. Abstracts are now available on the AACR website.
Insilico’s drug discovery efforts are driven by its validated and commercially viable AI drug discovery platform, Pharma.AI, ...
Study finds benefits in prescribing alcohol use disorder medications upon discharge from alcohol-related hospitalizations
2024-03-29
BOSTON – For adults hospitalized for alcohol-related reasons, receiving a prescription for an alcohol use disorder (AUD) medication at the time of discharge may lower their risk of return to hospital within 30 days of discharge, including emergency room visits and readmissions.
That’s according to a recent study published in JAMA Network Open led by researchers at Massachusetts General Hospital (MGH) and the University of Pittsburgh.
For the study, the investigators identified 9,834 alcohol-related hospitalizations among 6,794 Medicare Part D beneficiaries across the United States in 2016. Only 2.0% of hospitalizations involved filled ...